Patents by Inventor Tammie Jinkerson

Tammie Jinkerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (Indazol-4-yl) hexahydropyrrolopyrrolones and methods of use
    Patent number: 9682985
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein GAr, L1, Z1 and Z2 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Nav1.7 and/or Nav1.8. Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: June 20, 2017
    Assignee: AbbVie Inc.
    Inventors: Jerome Daanen, David DeGoey, Jennifer M. Frost, Tammie Jinkerson, Steve Latshaw, Lei Shi
  • (Indazol-4-YL) Hexahydropyrrolopyrrolones and Methods of Use
    Publication number: 20160264582
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein GAr, L1, Z1 and Z2 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Nav 1.7 and/or Nav 1.8. Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
    Type: Application
    Filed: March 14, 2016
    Publication date: September 15, 2016
    Applicant: AbbVie Inc.
    Inventors: Jerome Daanen, David DeGoey, Jennifer M. Frost, Tammie Jinkerson, Steve Latshaw, Lei Shi
  • ISOINDOLINONE KINASE INHIBITORS
    Publication number: 20110275630
    Abstract: Compounds having the formula: are useful for inhibiting protein kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: November 3, 2010
    Publication date: November 10, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Mark Matulenko, Tammie Jinkerson, Brian S. Brown, Wilfried Braje, Michael Curtin, Howard Robin Heyman, Victoria Scott, Karen Kage, Steven Cassar, Anil Vasudevan
  • Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
    Publication number: 20060148867
    Abstract: Compounds having formula (I) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein L, A, G, R1, R2 and R3 are as defined herein. These compounds are particularly useful in the treatment of pain, inflammatory hyperalgesia, and urinary dysfunctions, such as bladder overactivity and urinary incontinence.
    Type: Application
    Filed: December 5, 2005
    Publication date: July 6, 2006
    Inventors: Brian Brown, Tammie Jinkerson, Ryan Keddy, Chih-Hung Lee
  • Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
    Publication number: 20060148843
    Abstract: The present invention discloses fused thienopyridyl compounds of general formula (I) wherein X1-X6, R5-R7, Z1 and L are as defined in the description. The resent invention also discloses a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain, urinary incontinence, bladder overactivity, and inflammatory thermal hyperalgesia in mammals, and pharmaceutical compositions including those compounds.
    Type: Application
    Filed: December 2, 2005
    Publication date: July 6, 2006
    Inventors: Sean Turner, Tammie Jinkerson, Arthur Gomtsyan, Chih-Hung Lee
  • Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
    Publication number: 20060128689
    Abstract: Compounds that are antagonists of the VR1 receptor, having formula (I) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor.
    Type: Application
    Filed: November 22, 2005
    Publication date: June 15, 2006
    Inventors: Arthur Gomtsyan, Erol Bayburt, Robert Schmidt, Chih-Hung Lee, Brian Brown, Tammie Jinkerson, John Koenig, Jerome Daanen, Steven Latshaw
  • Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
    Publication number: 20050113576
    Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
    Type: Application
    Filed: August 4, 2004
    Publication date: May 26, 2005
    Inventors: Chih-Hung Lee, Erol Bayburt, Stanley DiDomenico, Irene Drizin, Arthur Gomtsyan, John Koenig, Richard Perner, Robert Schmidt, Sean Turner, Tammie Jinkerson, Guo Zheng